Despite neurological illness reports, JnJ Covid-19 vaccine benefits outweigh risks: US CDC advisers Ruchika Sharma23 July 2021 12:45 PM ISTNew Delhi: Despite reports of a rare neurological disorder appearing in some people who have received Johnson & Johnson's COVID-19 vaccine, the...
Drugmaker Endo to pay USD 35 million to settle opoid claims by Tennessee counties Ruchika Sharma23 July 2021 12:00 PM ISTNew Delhi: Endo International Plc has agreed to pay $35 million to settle a lawsuit by Tennessee local governments and on behalf of a child...
COVID vaccine IP waiver not property snatch, says WHO Ruchika Sharma23 July 2021 10:00 AM ISTGeneva: The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on Covid-19...
Glenmark arm to invest Rs 600 crore to double capacity in 4 years Ruchika Sharma23 July 2021 9:00 AM ISTMumbai: IPO-bound bulk drug manufacturer Glenmark Life Sciences is on track to more than double its capacity over the next four years at a cumulative...
Zydus Cadila Saroglitazar Mg gets Orphan Drug Designation from EMA Ruchika Sharma22 July 2021 3:17 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
COVID: Optimus Pharma submits phase 3 trials interim result for Molnupiravir capsules Ruchika Sharma22 July 2021 2:00 PM ISTOptimus has approached DCGI to seek Emergency Use Authorization for Molnupiravir in India, the release said.
Zydus Cadila to submit ZyCoV-D additional data to DCGI this week: Sources Ruchika Sharma22 July 2021 1:00 PM ISTNew Delhi: Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit...
Granules India arm clears USFDA audit Ruchika Sharma22 July 2021 12:03 PM ISTHyderabad: Granules India Limited has announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company located...
Strong quarter from Johnson and Johnson as some operations return to normal Ruchika Sharma22 July 2021 9:30 AM ISTNew Delhi: Johnson & Johnson's second-quarter profit soared 73%, thanks to strong sales growth across all of its businesses, particularly its...
Zydus Cadila gets USFDA nod for cancer drug Ibrutinib Ruchika Sharma21 July 2021 3:36 PM ISTAhmedabad: Drugmaker, Zydus Cadila, today announced that the company has received tentative approval from the United States Food & Drug...
Biogen Alzheimer's drug: Former FDA adviser calls for wider probe into approval Ruchika Sharma21 July 2021 2:00 PM ISTNew Delhi: A federal probe of the U.S. Food and Drug Administration's approval of a controversial new Alzheimer's disease drug should look into why...
Dabur India eyes strong Ayurvedic healthcare products demand Ruchika Sharma21 July 2021 1:56 PM ISTNew Delhi: FMCG major and medicines to make up for any loss in the discretionary products business in case the COVID-19 pandemic worsens, according to...
